Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21)
Ηλίας Δράκος(The University of Texas MD Anderson Cancer Center), L. Jeffrey Medeiros(The University of Texas MD Anderson Cancer Center)
Cited by 66
Related Papers
Activation of Mammalian Target of Rapamycin Signaling Promotes Cell Cycle Progression and Protects Cells from Apoptosis in Mantle Cell Lymphoma
|American Journal Of Pathology|2006|118
Lack of c-kit (CD117) expression in CD30+ lymphomas and lymphomatoid papulosis
|Modern Pathology|2004|24